Literature DB >> 16964282

Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression.

A Efeyan1, M Collado, S Velasco-Miguel, M Serrano.   

Abstract

Protein p21Cip1/Waf1 is transcriptionally activated by the tumour suppressor p53 and previous studies have shown that p21 plays a role in tumour suppression. However, the involvement of p21 in p53-mediated tumour suppression remains to be directly demonstrated in vivo. Tumour suppression mediated by p53 can be measured by comparing tumour susceptibility in animals carrying two (wild-type mice) or three (super-p53 mice) copies of the p53 gene. We have taken advantage of this genetically defined system to measure p53-mediated cell-cycle arrest, apoptosis and tumorigenesis, in a p21 wild-type and in a p21-null context. The absence of p21 significantly impaired the enhanced p53-mediated cell-cycle arrest characteristic of super-p53 cells, but did not affect the enhanced apoptosis. Importantly, in an experimental model of fibrosarcoma induction, the absence of p21 significantly decreased the tumour suppression benefit of super-p53 mice. We conclude that cell-cycle arrest through p21 plays a significant role in mediating p53-dependent cancer protection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16964282     DOI: 10.1038/sj.onc.1209972

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  p21 protects "Super p53" mice from the radiation-induced gastrointestinal syndrome.

Authors:  Julie M Sullivan; Laura B Jeffords; Chang-Lung Lee; Rafaela Rodrigues; Yan Ma; David G Kirsch
Journal:  Radiat Res       Date:  2011-12-13       Impact factor: 2.841

2.  Expression of Werner syndrome gene in hypothalamic neurons in physiological aging.

Authors:  E D Bazhanova; I G Popovich; V N Anisimov
Journal:  Dokl Biol Sci       Date:  2014-01-03

3.  Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.

Authors:  Colleen A Brady; Dadi Jiang; Stephano S Mello; Thomas M Johnson; Lesley A Jarvis; Margaret M Kozak; Daniela Kenzelmann Broz; Shashwati Basak; Eunice J Park; Margaret E McLaughlin; Anthony N Karnezis; Laura D Attardi
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

Review 4.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

5.  FATS is a transcriptional target of p53 and associated with antitumor activity.

Authors:  Xifeng Zhang; Qian Zhang; Jun Zhang; Li Qiu; Shuang-Shuang Yan; Juling Feng; Yan Sun; Xingxu Huang; Karen H Lu; Zheng Li
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

6.  Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.

Authors:  Meera Nanjundan; Kwai Wa Cheng; Fan Zhang; John Lahad; Wen-Lin Kuo; Rosemarie Schmandt; Karen Smith-McCune; David Fishman; Joe W Gray; Gordon B Mills
Journal:  Mol Oncol       Date:  2008-05-10       Impact factor: 6.603

Review 7.  Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

Authors:  Danielly C F Costa; Guilherme A P de Oliveira; Elio A Cino; Iaci N Soares; Luciana P Rangel; Jerson L Silva
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

8.  Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis.

Authors:  Nathan P Young; Denise Crowley; Tyler Jacks
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

9.  p21 as a transcriptional co-repressor of S-phase and mitotic control genes.

Authors:  Nuria Ferrándiz; Juan M Caraballo; Lucía García-Gutierrez; Vikram Devgan; Manuel Rodriguez-Paredes; M Carmen Lafita; Gabriel Bretones; Andrea Quintanilla; M Jose Muñoz-Alonso; Rosa Blanco; Jose C Reyes; Neus Agell; M Dolores Delgado; G Paolo Dotto; Javier León
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

10.  Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor.

Authors:  Dhrubajyoti Nag; Payel Bhanja; Randal Riha; Giselle Sanchez-Guerrero; Bruce F Kimler; Terance T Tsue; Chris Lominska; Subhrajit Saha
Journal:  Clin Cancer Res       Date:  2019-04-02       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.